Adviser
Lazard.
Financial adviser, Fairness opinion on 7 live deals, from 20 Mar 2025 to 11 Jun 2026.
07Live deals
20Other advisers
Deals
| Date | Deal | Stage | Role | Sector |
|---|---|---|---|---|
| 11 Jun 2026 | Chiesi Farmaceutici S.p.A. / KalVista Pharmaceuticals, Inc. | Closed |
| Not stated |
| 6 Feb 2026 | 2786694 Alberta Ltd. / SunOpta Inc. | Agreement signed |
| Consumer |
| 10 Dec 2025 | Atlas Holdings / The ODP Corporation | Closed |
| Technology |
| 26 Sep 2025 | Ferrero Group / WK Kellogg Co | Closed |
| Consumer |
| 2 Jun 2025 | GSK / Theravance Biopharma, Inc. | Agreement signed |
| Healthcare |
| 21 May 2025 | Paratek Pharmaceuticals, Inc. / OptiNose, Inc. | Closed |
| Healthcare |
| 20 Mar 2025 | QXO, Inc. / QXO Building Products, Inc. | Agreement signed |
| Not stated |
By year, sector and stage
| 2026 | 2 |
|---|---|
| 2025 | 5 |
| Consumer | 2 |
|---|---|
| Healthcare | 2 |
| Not stated | 2 |
| Technology | 1 |
| Closed | 4 |
|---|---|
| Agreement signed | 3 |
Other advisers on the same deals
| Adviser | Shared deals | Across the table | Alongside |
|---|---|---|---|
| J.P. Morgan | 2 | 1 | 1 |
| Skadden, Arps, Slate, Meagher & Flom LLP | 2 | 0 | 2 |
| Centerview | 1 | 1 | 0 |
| Centerview Partners LLC | 1 | 1 | 0 |
| Evercore | 1 | 1 | 0 |
| Evercore Group L.L.C. | 1 | 1 | 0 |
| Fenwick & West LLP | 1 | 1 | 0 |
| Goldman Sachs | 1 | 1 | 0 |
| Hogan Lovells US LLP | 1 | 1 | 0 |
| J.P. Morgan Securities LLC | 1 | 1 | 0 |
| Kirkland & Ellis LLP | 1 | 1 | 0 |
| Morgan Stanley | 1 | 1 | 0 |
| Simpson Thacher & Bartlett LLP | 1 | 1 | 0 |
| Davis Polk & Wardwell LLP | 1 | 0 | 1 |
| Lazard Frères & Co. LLC | 1 | 0 | 1 |
| Ropes & Gray LLP | 1 | 0 | 1 |
| Scotia Capital | 1 | 0 | 1 |
| Scotiabank | 1 | 0 | 1 |
| Wildeboer Dellelce LLP | 1 | 0 | 1 |
| Willkie Farr & Gallagher LLP | 1 | 0 | 1 |